Uloric Warning issued by the FDA – Uloric may increase risk of heart attacks and heart related deaths.
The lawyers and attorneys at National Injury Help are now investigating the drug Uloric (febuxostat) and its possible risk of heart related injury, heart attack and heart related deaths from this drug. There may be substantial cash settlements from these Uloric claims.
Consumer warning: If you are currently taking Uloric DO NOT STOP taking your medication, ask your doctor first.
What is Uloric used for?
Febuxostat, sold under the brand name Uloric, is a common drug used to treat a type of arthritis called gout. Gout is a condition that causes extreme pain, redness and swelling (inflammation) in joints. It is caused by high levels of uric acid in the kidneys that turns into needle shaped crystals deposited in the joints. Most common areas affected are the big toe joint, knees and ankles. Men suffer this condition more often than women.
In a recent study FDA’s Arthritis Advisory Committee and the Drug Safety and Risk Management Committee, found a higher mortality risk compared to another common gout drug allopurinol. The agency now states that Uloric should only be prescribed for patients who have tried allopurinol first. 
Public Agency asks FDA to remove Uloric from the market.
Public Citizen, a nonprofit consumer advocacy organization, urged the committee to recommend that the FDA immediately remove from the market the widely used gout medication febuxostat because it poses unique, serious risks – include the risk of dying from cardiovascular disease – but offers no unique benefit. Public Citizen had requested such action in a citizen petition submitted to the agency on June 21, 2018.
FDA Black Box Warning Issued for Uloric. Has Uloric been Recalled?
Excerpt: [2-21-2019] The U.S. Food and Drug Administration (FDA) has concluded there is an increased risk of death with Uloric (febuxostat) compared to another gout medicine, allopurinol. This conclusion is based on our in-depth review of results from a safety clinical trial that found an increased risk of heart-related death and death from all causes with Uloric.
As a result, we are updating the Uloric prescribing information to require a Boxed Warning, our most prominent warning, and a new patient Medication Guide. We are also limiting the approved use of Uloric to certain patients who are not treated effectively or experience severe side effects with allopurinol.
The FDA-mandated study, published in The New England Journal of Medicine in 2018, revealed that the “treatment with Uloric resulted in overall rates of major cardiovascular events that were similar to those associated with Allopurinol treatment among patients with gout who had coexisting cardiovascular disease. However, cardiovascular death and deaths from any cause were more frequent in the Uloric group than in the Allopurinol group”. 
At this time the FDA is not recalling Uloric from the market.
Help Filing an Uloric Lawsuit, Class action Status.
If you or someone you love has been prescribed the drug Uloric and has suffered any heart related injuries, heart attack or even death we can help. You may be eligible for a large cash compensation for your injuries. We make it easy filing an Uloric lawsuit, simply use the contact form on the bottom of this page or call us directly at 1-800-214-1010. We will never charge a fee for this consultation.
Join in the free Uloric Class Action Status & Investigation – MDL for Uloric
At the time of this writing the class action status of Uloric is undetermined. However we feel strongly that there is a case against Takeda Pharmaceuticals and it may in fact be granted an MDL (Multi District Litigation) status by the courts. Back in 2012 a former safety employee of Takeda came forth and made statements about the drug’s side effects and was granted a whistleblower lawsuit.
Our law firm is closely watching this new FDA warning and helping any person who may have been harmed by Uloric.
Sources:
https://www.fda.gov/Drugs/DrugSafety/ucm631182.htm
Uloric Lawsuit Attorneys & Lawyers | Claims & Settlements for Uloric page updated on 2/27/2019
